AGREEMENT WITH ASTRAZENECA (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Jun. 30, 2010	Jun. 30, 2007
Agreement With Astrazeneca Details Narrative
Research collaboration and license agreement with AstraZeneca			$ 5,000,000	$ 10,000,000
Revenue recognized under clinical trail sponsored research agreements	3,806	27,217	1,082,762
Milestone Payment Eligibility	145,250,000
Contingent Payment Eligibility	$ 85,250,000